Jade Biosciences (JBIO) Other Working Capital Changes (2020 - 2026)

Jade Biosciences (JBIO) has 2 years of Other Working Capital Changes data on file, last reported at -$29000.0 in Q1 2026.

• Quarterly Other Working Capital Changes fell 1173.77% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (up 65.33% YoY) and the FY2025 annual result came in at $12.0 million, up 4103.01% from the prior year.
• Other Working Capital Changes slipped to -$5.4 million in Q1 2026, from $10.2 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $10.2 million in Q4 2025 to a low of -$5.4 million in Q1 2026.
• A 5-year average of $388823.5 and a median of $265000.0 in 2024 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2025 — Other Working Capital Changes soared 3748.3% — and 2026, when it slumped 1173.77%.
• Tracing JBIO's Other Working Capital Changes over 2 years: stood at -$28000.0 in 2025, then dropped by 3.57% to -$29000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$29000.0 (Q1 2026), -$28000.0 (Q4 2025), and $9000.0 (Q1 2025), per Business Quant data.